33.09
Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
94.77%
10.88
|
207.83 | - | - | 7.00 |
|
|
6.10%
105.45
|
99.38 | 88.81 | 84.39 | 151.14 |
| Benefits Costs and Expenses |
6.27%
94.15
|
88.59 | - | - | - |
| Costs And Expenses |
39.80%
59.83
|
99.38 | - | - | - |
| Depreciation and Amortization |
0.00%
0.70
|
0.70 | 0.70 | 0.60 | 0.60 |
| Operating Income/Loss |
187.20%
-94.57
|
108.45 | -88.81 | -84.39 | -144.14 |
| Nonoperating Income/Loss |
4.68%
11.30
|
10.79 | 11.31 | 12.21 | 13.83 |
| Income/Loss From Continuing Operations Before Tax |
169.83%
-83.27
|
119.24 | -77.49 | -72.18 | -130.31 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
169.83%
-83.27
|
119.24 | -77.49 | -72.18 | -130.31 |
|
|
169.83%
-83.27
|
119.24 | -77.49 | -72.18 | -130.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.96%
0.0328
|
88.53 | 88.47 | 88.36 | 1.9013 |
| Diluted Average Shares |
99.96%
0.0328
|
89.69 | 88.47 | 88.36 | 1.9013 |
| Basic Earnings Per Share |
169.63%
-0.94
|
1.35 | -0.88 | -0.82 | -1.55 |
| Diluted Earnings Per Share |
170.68%
-0.94
|
1.33 | -0.88 | -0.82 | -1.55 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):